MIRA INFORM REPORT

 

 

Report Date :

13.01.2012

 

IDENTIFICATION DETAILS

 

Correct Name :

SX BIOTECH CO., LTD

 

 

Registered Office :

MEIC Building, Narnyi Zam Street 63, 232, Ulaanbaatar 210628

 

 

Country :

Mongolia

 

 

Date of Incorporation :

22.04.2008

 

 

Com. Reg. No.:

9011150009

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Trading as importers, wholesalers and retailers of laboratory equipment, instruments, chemicals, diagnostics and reagents.

 

 

No. of Employees :

7

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

TUGRIK 10,000,000

 

 

Status :

Small company

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

Mongolia

C1

C1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Company name

 

SX Biotech Co., Ltd (Correct)

SX Biotech Office (Requested)

 

 

Company ADDRESS

 

Building             : MEIC Building

Street               : Narnyi Zam Street 63

P.O.Box No.      : 232

Town                 : Ulaanbaatar 210628

Country             : Mongolia

 

Telephone         : (976 50) 060 677 / (976 99) 040 584 (Erdene Chimeddorj) / (976 88) 132 385

Fax                   : (976 11) 323 877

E-Mail               : erdene@sxbiotech.mn / ayush@sxbiotech.mn

 

Shortform Name: SXB Co., Ltd

 

 

SENIOR COMPANY PERSONNEL

 

 

   Name                                 Position

 

1. Erdene Chimeddorj                    Executive Director

 

2. Ayush Erdene                         Sales Manager

 

3. Ninjbadam Enkhbaatar                 Sales Manger      

 

Total Employees : 7

 

 

PAYMENTS

 

No complaints have been heard regarding payments from local suppliers or banks.

 

We consider it is acceptable to deal with subject for SMALL amounts,

although it is normal accepted practice for international suppliers to deal on secured terms with Mongolian importers.

 

Opinion on maximum credit : TUGRIK 10,000,000

 

Trade risk assessment: Normal

 

PRINCIPAL BANKERS

 

NAME               : TRADE AND DEVELOPMENT BANK OF MONGOLIA

 

Branch              : Zanabazar Branch, Chingeltei District, Trade Street 7

Town                 : Ulaanbaatar

 

Telephone         : (976 11) 312 356 / 328 531 / 329 413

Fax                   : (976 11) 311 025

 

 

FINANCIAL INFORMATION

 

Private companies in Mongolia are not required to publish or disclose balance sheets. However, the subject interviewed offered the following information :

 

Sales Turnover               : TUGRIK 350,000,000 - 2010 - exact

                                                : TUGRIK 490,000,000 - 2011 - exact

                                                : TUGRIK 700,000,000 - 2012 - projected

 

Net Profit                       : TUGRIK  50,000,000 - 2010 - exact

                                                : TUGRIK  70,000,000 - 2011 - exact

 

Total value of current contracts :  US DLRS 127,000

 

Financial year ends 31 December.

 

 

LEGAL STATUS AND HISTORY

 

Date Started                  : 22 April 2008

 

C.R. No.                        : 9011150009

 

Tax No.                         : 5221293

 

Authorised Capital          : TUGRIK 4,000,000 

 

Paid-Up Capital : TUGRIK 4,000,000 

 

Limited Liability Company with the following shareholders:

 

                                                            Percentage

 

1. Erdene Chimeddorj                               50% 

  (Mongolian national)

 

2. Zanabazar Enkhbaatar                            50%  

  (Mongolian national)    

 

 

ACTIVITIES

 

The Company is involved in the following activities :

 

Trading as importers, wholesalers and retailers of laboratory equipment, instruments, chemicals, diagnostics and reagents.

 

NACE Code: 4675

 

Imports from USA, South Korea, Japan, Germany, Finland, Belgium and China.

 

Subject does not export, all sales are domestic.

 

Subject’s suppliers include:

 

1. Cole Parmer International

   USA

   Telephone      : (1 65) 9690 8208

   E-Mail            : fning@coleparmer.com

   Contact person: Francis Ning - Asia Business Manager

 

2. Carl Roth GmbH

   Schoemperlenstr. 1-5,

   Karlsruhe 76185

   Telephone      : (49) 721 5606

   Fax                : (49) 721 5606

   E-Mail            : info@carlroth.de

   Contact Person: Wolfgang Treffinger - Export Mangaer

 

3. Intron Biotechnology, INC

   South Korea

   Telephone      : (82 2) 449 2381

   E-Mail             : besieger@intronbio.com

   Contact Person: Lumy Kwon - Export Manager   

 

 

FACILITIES

 

The Company has the following facilities :

 

200 sq. m. rented premises comprising administrative offices and storage facilities located at the heading address.

 

Until 2011 subject was located at :

 

Nisora Tower 604, Tokyo Street 14A

Ulaanbaatar

 

 

REGISTERED OFFICE

 

MEIC Building

Narnyi Zam Street 63

P.O.Box No.: 232

Ulaanbaatar 210628

 

 

SPECIAL NOTE

 

You enquired on: SX Biotech Office. Please note that the correct name is as per heading.  

 

Interviewed: Erdene Chimeddorj (Executive Director).

 

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.51.83

UK Pound

1

Rs.79.42

Euro

1

Rs.65.90

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.